Posted by Clinical Lab Products | Dec 9, 2009 | Miscellaneous |
The market for personalized medicine in the US is already $232 billion, and it is projected to grow 11% annually, according to a new report published today by PricewaterhouseCoopers LLP, entitled The Science of Personalized Medicine: Translating the Promise into Practice.
Read MorePosted by Clinical Lab Products | Dec 7, 2009 | Cancer, Hematology & Serology, Hematology Instrumentation, Miscellaneous |
PLUS Diagnostics announced that it has expanded its specialty anatomic pathology services with the launch of a national hematology/oncology offering.
Read MorePosted by Clinical Lab Products | Dec 4, 2009 | Cancer, Miscellaneous |
Quest Diagnostics will present new discoveries during the 51st American Society of Hematology (ASH) Annual Meeting and Exposition in New Orleans.
Read MorePosted by Clinical Lab Products | Dec 3, 2009 | Miscellaneous |
The American College of Medical Genetics (ACMG) has a long-standing position that genes are products of nature, and as such should not be patentable.
Read MorePosted by Clinical Lab Products | Dec 2, 2009 | Cancer, Miscellaneous |
Guardian Technologies International introduces Signature Mapping TBDx (TBDx), an automated diagnostic solution using sophisticated detection algorithms to identify TB under microscopy in sputum samples, at the laboratory level.
Read More